Sudair Pharma proudly participated in the Local Content Forum 2024, one of the Kingdom’s key platforms dedicated to accelerating national industry growth and strengthening local capabilities. Throughout the event, the company highlighted its expanding contribution to Saudi Arabia’s pharmaceutical ecosystem through several initiatives, activities, and strategic engagements.
Launch of Sudair Pharma’s “Ghrs” Local Content Development Program
During the forum, Sudair Pharma officially launched its new Ghrs Program, a dedicated initiative designed to advance local content, support sustainable innovation, and reinforce national pharmaceutical security. The launch was unveiled on stage in partnership with the Local Content and Government Procurement Authority (LCGPA).
Executive Participation in Panel Discussions
Sudair Pharma’s CEO, Dr. Yasser Alobaida, participated in a high-level panel titled “The Impact of Local Content on the Healthcare Sector.”
During the discussion, he shared insights on how local manufacturing, strategic partnerships, and innovation play a vital role in meeting national healthcare demands and reducing dependency on imports.
Workshops Led by Sudair Pharma Leadership
The company’s Chief Business Officer, Mr. Mustafa Aljaser, led a workshop focused on best global practices in local content development.
The session explored strategic approaches for advancing the Kingdom’s pharmaceutical capabilities and enhancing supply chain resilience.
Sudair Pharma Booth Activities & Government Engagement
Sudair Pharma’s booth welcomed senior officials, industry leaders, and visitors who engaged with the company’s long-term vision, innovative pharmaceutical solutions, and localization achievements.
The company had the honor of hosting the Minister of Industry and Mineral Resources, who reviewed Sudair Pharma’s contributions to localizing essential medicines and its future expansion roadmap.
Highlighting National Achievements in Local Content
Throughout the forum, Sudair Pharma showcased its growing portfolio of localized products, capacity expansions, and partnerships that support national goals in medicine manufacturing and supply chain integration.
Commitment to Vision 2030
Sudair Pharma reaffirmed its commitment to playing a leading role in advancing local content in the pharmaceutical sector, contributing to healthcare sustainability, national competitiveness, and Saudi Arabia’s ambition to become a regional hub for innovation.
